Efficacy of the Telemedical Lifestyle intervention Program TeLiPro in Advanced Stages of Type 2 Diabetes: A Randomized Controlled Trial

31. Juli 2017

Lifestyle interventions are the foundation of treatment in newly diagnosed type 2 diabetes. However, their therapeutic potential in advanced disease stages is unknown. We evaluated the efficacy of the Telemedical Lifestyle intervention Program (TeLiPro) in improving metabolic control in advanced-stage type 2 diabetes.

http://care.diabetesjournals.org/content/diacare/40/7/863.full.pdf

Autoren: Kerstin Kempf, Bernd Altpeter, Janine Berger, Oliver Reuß, Matthias Fuchs, Michael Schneider, Babette Gartner, Katja Niedermeier and Stephan Martin

Prof. Dr. Martin

Chefarzt für Diabetologie und Direktor des Westdeutschen Diabetes- und Gesundheitszentrum (WDGZ) in Düsseldorf